arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Immunome Inc.

IMNM

$17.91 ▼ -1.59 (-8.15%) at close

30 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Immunome Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.0B

Dividend Yield —

Revenue Growth N/M

Op. Margin None

ROIC -11.8% ↘

FCF / Share $-0.56 ↘

Trailing P/E —

Price / Book 3.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

30-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-53.84M

↓ -29.3% —

Operating Margin Operating profit as % of sales

-130.0%

↑ +4.0% —

FCF / Share Free cash flow per share

$-0.56

↑ +2.5% —

Long-Term Debt Long-term obligations

$500.00K

↑ +273.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	N/M	N/M	N/M	N/M	69.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+773%)	184.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2204%)	-28.4% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-455%)	-18.4% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-330%)	-44.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-657%)	-56.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-806%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-30.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	7.7% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	41.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	16.7% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	16.7% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	79.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	69.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-116.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-30.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-617.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-559.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	52.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	37.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	63.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	1.5% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-15.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-60.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-29.3% Weak ↓ Weak Declining Year-over-year change in net income	-29.3% Weak ↓ Weak Declining Year-over-year change in net income	12.9% Fair ↓ Fair Declining Year-over-year change in net income	67.8% Excellent ↑ Excellent Improving Year-over-year change in net income	67.8% Excellent ↑ Excellent Improving Year-over-year change in net income	67.8% Excellent ↑ Excellent Improving Year-over-year change in net income	13.4% Fair ↑ Fair Improving Year-over-year change in net income	-2932.6% Weak ↓ Weak Declining Year-over-year change in net income	-2932.6% Weak ↓ Weak Declining Year-over-year change in net income	-2932.6% Weak ↓ Weak Declining Year-over-year change in net income	-1089.8% Weak ↓ Weak Declining Year-over-year change in net income	50.0% Excellent ↑ Excellent Improving Year-over-year change in net income	52.2% Excellent ↑ Excellent Improving Year-over-year change in net income	63.4% Excellent ↑ Excellent Improving Year-over-year change in net income	0.8% Caution ↑ Caution Improving Year-over-year change in net income	-10.5% Weak ↑ Weak Improving Year-over-year change in net income	-70.3% Weak ↑ Weak Improving Year-over-year change in net income	-198.9% Weak ↓ Weak Declining Year-over-year change in net income	-92.8% Weak ↓ Weak Declining Year-over-year change in net income	7.8% Fair ↑ Fair Improving Year-over-year change in net income	-93.4% Weak → Weak Stable Year-over-year change in net income	-45.6% Weak ↑ Weak Improving Year-over-year change in net income	-39.4% Weak Weak Year-over-year change in net income	-206.1% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	2.5% Caution ↓ Caution Declining Year-over-year change in free cash flow	23.7% Good ↑ Good Improving Year-over-year change in free cash flow	—	20.2% Good ↑ Good Improving Year-over-year change in free cash flow	-34.6% Weak ↑ Weak Improving Year-over-year change in free cash flow	-176.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	—	16.3% Good Good Year-over-year change in free cash flow	12.8% Fair Fair Year-over-year change in free cash flow	N/M	—	-13.6% Weak Weak Year-over-year change in free cash flow	27.4% Excellent Excellent Year-over-year change in free cash flow	N/M	—	-78.6% Weak Weak Year-over-year change in free cash flow	-107.4% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	-130.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-966%)	-135.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1003%)	-189.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1361%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	-119.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1098%)	-100.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-935%)	-180.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1605%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	-465.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-242.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-140.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.21x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.36x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.19x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	2.03x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.41x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-5.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.89x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.50x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.68x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-11.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-36.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-36.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-62.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-60.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-36.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.6% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	5.3% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	5.5% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	6.4% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	6.6% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-13.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-13.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-34.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-41.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-63.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-9.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-32.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-24.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-13.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-9.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-23.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-57.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-10.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-168%)	-9.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	-11.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-15.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-205%)	-15.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-203%)	-13.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-190%)	-44.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-395%)	-60.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-502%)	-51.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-440%)	-45.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-402%)	-77.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-615%)	-70.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-569%)	-45.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-405%)	-30.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-305%)	-46.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-412%)	-37.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-346%)	-29.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-296%)	-30.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-305%)	-16.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	-14.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-8.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-10.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	-9.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	17.1% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+14%)	6.6% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-56%)	7.0% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-53%)	8.2% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-45%)	8.4% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-44%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.01x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	-0.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-102%)	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-1568.80x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2574.33x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5740.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1948.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2036.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-281.80x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-678.75x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-204.23x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-84.94x Weak Weak Operating income divided by interest expense Optimal: > 5x	-160.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-217.71M	$-582.69M	$-653.48M	$-272.64M	$-143.88M	$-257.61M	$-143.35M	$-155.57M	$-165.33M	$-269.72M	$-98.68M	$-90.64M	$-38.42M	$-44.42M	$-20.32M	$-27.08M	$-34.65M	$-42.88M	$-49.23M	$-56.24M	$-59.83M	$-35.78M	$-39.63M	$-6.24M	$-9.79M	—	$-2.54M	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.13x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.04x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.18x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	—	$0.00	$0.05	$0.04	—	$0.05	$0.04	$0.02	—	$0.29	$0.35	$0.19	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.65	$-0.48	$-0.75	$-0.65	$-0.50	$-0.52	$-1.28	$-0.78	$-0.60	$-2.51	$-4.22	$-0.36	$-0.46	$-0.35	$-0.64	$-0.75	$-0.74	$-0.96	$-0.65	$-0.65	$-0.46	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.56	$-0.54	—	$-0.47	$-0.58	$-0.71	—	$-0.59	$-0.43	$-0.26	—	$-0.71	$-0.49	$1.98	—	$-0.62	$-0.68	$-0.53	—	$-0.35	$-0.33	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$4.63	$5.20	$5.61	$2.88	$3.09	$3.53	$2.81	$3.57	$4.24	$4.78	$2.77	$0.50	$0.77	$1.14	$1.37	$1.90	$2.50	$3.12	$3.98	$4.59	$5.29	$3.55	$3.89	$-261.82	—	—	$-32.41	—	—	—
Tangible Book Value per Share (USD)	$4.63	$5.20	$5.61	$2.88	$3.09	$3.53	$2.81	$3.57	$4.24	$4.78	$2.77	$0.50	$0.77	$1.14	$1.37	$1.90	$2.50	$3.12	$3.98	$4.59	$5.29	$3.55	$3.89	$-261.82	—	—	$-32.41	—	—	—
Basic Weighted Avg Shares (shares)	113.27M	113.14M	—	87.96M	87.01M	79.41M	—	60.21M	59.94M	51.54M	—	12.20M	12.20M	12.18M	—	12.13M	12.13M	12.12M	—	11.93M	11.46M	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$502.74M	$566.90M	$615.79M	$248.48M	—	$292.33M	$167.03M	—	—	$282.56M	$122.87M	—	—	$21.70M	$15.32M	—	—	$36.60M	$46.91M	—	—	$36.54M	$39.86M	$2.08M	—	—	$1.46M	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$500.00K	$134.00K	$500.00K	—	—	—	—	—	—
Total Equity (USD)	$525.08M	$588.69M	$634.34M	$263.92M	$269.27M	$307.13M	$181.16M	$214.91M	$253.84M	$285.57M	$119.88M	$6.08M	$9.34M	$13.86M	$16.65M	$23.08M	$30.28M	$37.87M	$48.19M	$54.79M	$60.62M	$37.88M	$41.34M	$-49.09M	$-40.83M	$-38.16M	$-35.63M	$-32.72M	$-29.98M	$-25.20M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$0.00	$0.00	$4.01M	$2.93M	$2.74M	$2.91M	$2.36M	$1.03M	$3.83M	$3.56M	$4.26M	$2.36M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$957.00K	$603.00K	$629.00K	$589.00K	$637.00K	$611.00K	$450.00K	$411.00K	$549.00K	$157.00K	$151.00K	$111.00K	$101.00K	$94.00K	$95.00K	$103.00K	$113.00K	$111.00K	$118.00K	$286.00K	$175.00K	$176.00K	$256.00K	—	$159.00K	$163.00K	$161.00K	—	—	—
Net Income, GAAP (USD)	$-53.84M	$-53.84M	$-69.90M	$-41.64M	$-41.64M	$-41.64M	$-80.25M	$-129.49M	$-129.49M	$-129.49M	$-92.63M	$-4.27M	$-4.27M	$-4.27M	$-7.79M	$-8.53M	$-8.92M	$-11.65M	$-7.85M	$-7.72M	$-5.24M	$-3.90M	$-4.07M	$-8.38M	$-2.71M	$-2.68M	$-2.92M	$-2.74M	—	—
Operating Cash Flow (USD)	$-61.69M	$-58.64M	$-47.95M	$-40.51M	$-49.40M	$-53.05M	$-42.06M	$-34.17M	$-23.40M	$-11.17M	$-17.46M	$-8.61M	$-5.67M	$24.17M	$-6.68M	$-7.57M	$-8.06M	$-6.38M	$-6.80M	$-4.14M	$-3.74M	$-3.54M	$-6.06M	—	$-1.48M	$-2.06M	$-2.58M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 8 years · 30 quarters

Immunome Inc.

Analytical Summary

30-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare IMNM with peers